The GERD market size will increase by USD 908.49 million; North America will provide 38% of market growth

NEW YORK, January 24, 2023 /PRNewswire/ — The GERD Market by Route of Administration, Type and Geography – Forecast and Analysis 2023-2027 the report was published by Technavio. The market size is expected to grow by 908.49 million US dollars between 2022 and 2027 on a CAGR of 3.4%. The report provides a comprehensive analysis of regional growth opportunities, new product launches, latest trends, and post-pandemic global market recovery. Download a PDF sample report

Technavio has announced its latest market research report titled Global GERD Market 2023-2027

Regional analysis

By region, the global GERD market is segmented into North America, Europe, Asiaand the rest of the world (ROW). North America will report 38% market growth during the forecast period. Factors such as increasing preference for over-the-counter drugs and self-medication practice among the population are driving the growth of the GERD market in North America. Buy the report

Company profiles

The GERD market report includes information on the key products and recent developments of leading vendors, including:

  • Bayer AG – The company offers GERD drugs such as abbott pantoprazole.

  • Alkem Laboratoris EOOD – The company offers drugs for GERD such as esokem and omee.

  • Apotex Inc. – The company offers GERD drugs such as famotidine.

  • AstraZeneca Plc – The company offers GERD drugs such as nexium 20 mg.

Market dynamics

The market is driven by factors such as the growing geriatric population, poor lifestyles, and excessive use of drugs and nutritional supplements. However, the growing preference for CAM of complementary and alternative medicine is hindering the growth of the market.

Competitive analysis

The competitive scenario categorizes companies based on various performance metrics. Some of the factors considered include companies’ financial performance over the past few years, growth strategies, product innovation, new product launches, investments and market share growth, among others. Request a sample

Market segmentation

  • By administration, the market is segmented into oral and parenteral. The oral segment accounts for the largest share of the market in 2022.

  • By geography, the market is segmented into North America, Europe, Asiaand the rest of the world (ROW). North America hold the largest share of the market in 2022.

Related reports:

  • The human combination vaccine market is expected to grow at a CAGR of 8.13% between 2022 and 2027. The market size is expected to increase by 6,046.98 million US dollars. The rise in the incidence of infectious diseases is significantly driving the market growth, although factors such as incompatibility of vaccine components may hinder the market growth.

  • The food market is expected to grow at a CAGR of 4.48% between 2022 and 2027. The market size is expected to increase by $34.79 billion. The growing geriatric population in particular is driving the growth of the market, although factors such as product recalls may hinder the growth of the market.

Technavio’s library includes over 17,000+ reports covering more than 2,000 emerging
Subscribe to our “Basic Plan” on samo 5000 USD and get lifetime access to
Technavio Insights

What are the key data included in this GERD market report?

  • Market CAGR during the forecast period.

  • Detailed information on factors that will drive market growth between 2023 and 2027

  • An accurate estimate of the GERD market size and its contribution to the parent market.

  • Accurate predictions of upcoming trends and changes in consumer behavior.

  • Market growth North America, Europe, Asiaand the rest of the world (ROW).

  • In-depth analysis of the competitive landscape of the market and detailed information on suppliers.

  • A comprehensive analysis of the factors that will drive the growth of vendors in the GERD market.

Market scope of GERB

Report coverage


Page number


Base year


Historical period


Estimated period


Growth momentum and CAGR

Accelerate at a CAGR of 3.4%

Market Growth 2023-2027

908.49 million US dollars

Market structure

Torn apart

Year-on-year growth 2022-2023 (%)


Regional analysis

North America, Europe, Asia and Rest of World (ROW)

Effective market contribution

North America with 38%

Key countries

USA, Canada, Germany, UK and China

The competitive environment

Leading suppliers, market positioning of suppliers, competitive strategies and industry risks

Key companies profiled

Bayer AG, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, iNova Pharmaceuticals, Johnson and Johnson, Lupine Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., The Procter and Gamble Co. and Abbott Laboratories

Market dynamics

Major market analysis, drivers and barriers to market growth, fast and slow growing segment analysis, analysis of the impact and recovery of COVID-19 and future consumer dynamics, and market status analysis for the forecast period.

Range of customization

If our report doesn’t include the data you’re looking for, you can contact our analysts and get custom segments.


1 Summary

2 Market landscape

3 Sizing the market

4 Historical market size

5 Five Forces Analysis

6 Market segmentation by route of administration

7 Market Segmentation by Type

8 Customer landscape

9 Geographical landscape

10 Drivers, challenges and trends

11 Supplier landscape

12 Supplier Analysis

13 Appendix

About us
Technavio is a leading global technology research and consulting company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 dedicated analysts, Technavio’s report library consists of more than 17,000 reports and growing, covering 800 technologies spanning 50 countries. Their client base consists of businesses of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, in-depth research and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media and Marketing Executive
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]

Global GERD Market 2023-2027

Global GERD Market 2023-2027



View Original Media Download Content: for -38-on-market-growth—technavio-301728015.html

SOURCE Technavio

Leave a Comment

Your email address will not be published. Required fields are marked *